Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial
NCT07332221
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
435
Enrollment
OTHER_GOV
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Toripalimab monotherapy
Sponsor
Henan Cancer Hospital